Related Experiment Video

Updated: Oct 17, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk

R B Zotz1, M Klein, H P Dauben

  • 1Department of Haemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, Germany. zotz@med.uni-duesseldorf.de

Thrombosis and Haemostasis
|April 1, 2000
PubMed

Insights

Human Platelet Antigen 1b (HPA-1b) is a hereditary risk factor for adverse outcomes after coronary artery bypass surgery. This includes bypass occlusion, myocardial infarction, or death, highlighting its clinical significance.

Area of Science:

  • Cardiovascular Medicine
  • Immunogenetics
  • Surgical Outcomes

Background:

  • Human Platelet Antigen 1b (HPA-1b) is a known risk factor for thrombogenicity and myocardial infarction in patients with coronary artery disease.
  • HPA-1b is not a risk factor for coronary artery disease itself.
  • The role of HPA-1b in outcomes following coronary artery bypass grafting (CABG) remains to be elucidated.

Purpose of the Study:

  • To investigate the association between HPA-1b genotype and clinical outcomes in patients undergoing saphenous-vein coronary-artery bypass grafting.
  • To determine if HPA-1b is an independent risk factor for postoperative complications after CABG.

Main Methods:

  • Prospective determination of HPA-1 genotype in 261 consecutive patients before CABG.
  • One-year follow-up to assess for bypass occlusion, myocardial infarction, or death.
  • Stepwise logistic regression analysis including clinical and demographic variables.

Main Results:

  • A significantly higher prevalence of HPA-1b was observed in patients with postoperative complications (60%) compared to those without (24%).
  • HPA-1b was independently associated with an increased risk of bypass occlusion, myocardial infarction, or death (odds ratio 4.7, p=0.019).
  • No other tested variables (age, sex, BMI, smoking, hypertension, diabetes, lipids) showed a significant independent association.

Conclusions:

  • HPA-1b is a significant hereditary risk factor for adverse outcomes after coronary artery bypass surgery.
  • The presence of HPA-1b is linked to increased risks of bypass occlusion, myocardial infarction, and mortality post-CABG.
  • These findings suggest HPA-1b genotyping may aid in risk stratification for patients undergoing CABG.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...